Your session is about to expire
← Back to Search
Procedure
Group 1: with baseline anxiety+catheter ablation for Atrial Fibrillation (AWARE Trial)
N/A
Waitlist Available
Led By Mitra Mohanty, MD MS FHRS
Research Sponsored by Texas Cardiac Arrhythmia Research Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Summary
This trial will study how anxiety affects heart health in women with different types of irregular heartbeats.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Recurrence status
Trial Design
2Treatment groups
Active Control
Group I: Group 1: with baseline anxiety+catheter ablationActive Control1 Intervention
Baseline anxiety will be defined as; Cardiac Anxiety Questionnaire (CAQ) score \>2.14 Hospital Anxiety and Depression Questionnaire (HAD) \>7 State-Trait Anxiety Inventory (STAI): State-anxiety score \>40
Group II: Group 2: Without baseline anxiety + catheter ablationActive Control1 Intervention
Cardiac Anxiety Questionnaire (CAQ) score \<2.14 Hospital Anxiety and Depression Questionnaire (HAD) \<7 State-Trait Anxiety Inventory (STAI): State-anxiety score \<40
Find a Location
Who is running the clinical trial?
Texas Cardiac Arrhythmia Research FoundationLead Sponsor
38 Previous Clinical Trials
15,254 Total Patients Enrolled
27 Trials studying Atrial Fibrillation
8,519 Patients Enrolled for Atrial Fibrillation
Mitra Mohanty, MD MS FHRSPrincipal InvestigatorTexas Cardiac Arrhythmia Research Foundation
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger